Beltran Pedro — SEC insider filings
SEC reporting owner CIK 2058152. 7 insider filings on record with FilingPulse; latest filed 2026-11-20.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2025-08-28 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 1,870 shares, $3,443 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 1,870 shares @ $1.84 ($3,443) in BridgeBio Oncology Therapeutics, Inc., filed 2026-11-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | President and CEO, Director | 7 | — | 1 leg · 1,870 sh · $3,443 | 7 |
Insider filings — Beltran Pedro
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-20 | 4 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Sale (S): 1,870 @ $1.84 | EDGAR |
| 2026-10-05 | 4 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Tax withholding (F): 1,047 @ $3.94 | EDGAR |
| 2026-07-06 | 4 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Tax withholding (F): 1,047 @ $7.80 | EDGAR |
| 2026-05-12 | 4 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Grant/award (A): 1,103,837 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Tax withholding (F): 1,047 @ $9.03 | EDGAR |
| 2026-03-12 | 4 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Grant/award (A): 46,670 @ $0 · Grant/award (A): 210,000 (derivative) @ $0 | EDGAR |
| 2025-08-28 | 4 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Grant/award (A): 357,177 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2058152 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs